Back to results
US 6,723,712 B2Granted
Antiviral agent for use in treatment of cancer
AssigneesInstitut Gustave Roussy, Universite Paris-Sud Xi
InventorsJean Bourhis, Bassam Abdulkarim, Eric Deutsch
Life of this patent
Estimating the term…
Abstract
The invention relates to an antiviral agent for use in combination with an anticancer agent, for the treatment of cancer. Especially, the invention provides means for the treatment of non-virus-associated cancer.
Claims7
A method of treating a virus-associated cancer comprising:
- administering to an individual an antiviral agent and an anti-cancer treatment, wherein said administration of both said antiviral agent and said anti-cancer treatment results in a synergistic effect and wherein the antiviral agent is HPMPC [(S)-1-[3-hydroxy-2-(phosphomethoxy)propyl]cytosine] and the anticancer treatment is radiotherapy.
A method of treating a lymphoma or a carcinoma, comprising:
- administering to an individual an antiviral agent and an anti-cancer treatment, wherein said administration of both said antiviral agent and said anti-cancer treatment results in a synergistic effect.
Dependencies are inferred from the claim text.